This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.

High-risk compound

Surface here is educational only; do not use without medical supervision. Our editorial verdict is SKIP-FOR-NOW — current cost / risk / redundancy puts it below the line.

Browse

Liposomal Glutathione

Emerging

Phospholipid-encapsulated GSH does fix the GI bioavailability problem of plain glutathione (B-tier evidence: Sinha 2018 — +25% RBC GSH,…

Aliases (5)
Lipo-GSH · Liposomal GSH · Quicksilver Glutathione · ReadiSorb Glutathione · Liposomal-Encapsulated Reduced Glutathione
TYPICAL DOSE
500 mg
Daily
ROUTE
Oral (capsule)
Oral
CYCLE
Continuous use is fine; cycling not mechanistic…
Continuous / daily
STORAGE
Room temp; cool dry place
Room temp

Overview

What is Liposomal Glutathione?

Liposomal glutathione is reduced glutathione (GSH) encapsulated in phospholipid vesicles for improved oral bioavailability. It is used as the body's master antioxidant supplement.

Key Benefits

Raises systemic glutathione levels more reliably than non-liposomal oral GSH, supports detoxification and Phase II conjugation, scavenges reactive oxygen species, and may improve markers of oxidative stress.

Mechanism of Action

Liposomal encapsulation protects glutathione from gastric breakdown and improves intestinal and lymphatic absorption. The cysteine thiol then reduces hydrogen peroxide and lipid peroxides via glutathione peroxidase and conjugates electrophilic toxins via glutathione-S-transferase.

Pharmacokinetics

·
PeakHalf-life
Approximate curve — visual aid only, not data-precise PK
Brand options4 known
Lipo-GSHLiposomal GSHQuicksilver GlutathioneReadiSorb Glutathione

StatusOTC supplement (US, EU, CA)

Peptide Interactions

n-acetyl-cysteine:
Synergistic

Provides cysteine substrate for endogenous GSH synthesis — works through a different door than direct GSH delivery. Together, NAC handles brain side + substr…

Vitamin C (V4):
Synergistic

Recycles oxidized GSH back to reduced form via the GSH-ascorbate cycle.

Selenium:
Synergistic

Cofactor for glutathione peroxidase (GPx) — without selenium, GSH can't do its peroxide-quenching job.

Alpha-lipoic acid (R-ALA):
Synergistic

Recycles GSH and crosses cell membranes; classic antioxidant network partner.

taurine:
Synergistic

Complementary antioxidant with osmolyte + membrane-stabilizing roles; non-redundant.

Curcumin (V4):
Synergistic

Upregulates Nrf2 → endogenous GSH synthesis machinery.

s-acetyl-glutathione:
Avoid

Redundant — both are oral GSH delivery formats. Pick one. Liposomal has stronger PK data.

Direct plain oral GSH:
Avoid

Wasted money — PK is poor.

Quality Indicators

Tested third-party COA

Reputable brands publish a Certificate of Analysis for identity, potency, and contaminant testing.

GMP-certified manufacturing

Look for cGMP / NSF / USP certifications on the label.

!

Proprietary blends

Avoid products that hide individual ingredient amounts inside a "proprietary blend."

No origin or sourcing info

Unbranded or no-COA capsules from anonymous sellers carry quality and adulteration risk.

What to Expect

  • Week 1
    Baseline tolerability. Most chronic-use supplements have no acute signal.
  • Week 2-4
    Subtle baseline shift — sleep quality, mood, recovery markers.
  • Week 4-8
    Reach steady state. Re-assess subjective + objective markers.
  • Month 3+
    Long-term maintenance dose if benefit confirmed; otherwise stop.

Side Effects & Safety

  • Common (>10%): None consistently reported. Some users get mild GI discomfort, loose stool, sulfur burps (cysteine-derived).
  • Less common (1-10%): Headache (rare), skin breakout (transient, theoretically mobilization of toxins).
  • Rare-serious (<1%): No serious AEs documented in the small trials. Asthma exacerbation possible at high doses (debated, mostly with NAC, less with GSH itself).
  • Specific watch periods: None. GSH is endogenous; toxicity profile is benign.

References

Sinha et al. 2018, Eur J Clin Nutr (PMID 28853742)

pubmed.ncbi.nlm.nih.gov · 2018

pivotal liposomal GSH bioavailability + immune function trial, n=12, open-label

View Study

Sinha 2018 PMC version

pmc.ncbi.nlm.nih.gov · 2018

full text

View Study

Schmitt et al. 2015, NAC vs oral GSH vs sublingual GSH crossover

pmc.ncbi.nlm.nih.gov · 2015

formulation matters

View Study

Liposomal GSH metabolomic crossover 2026, MDPI Antioxidants

mdpi.com · 2026

recent dose-normalized comparison

View Study

Kumar et al. 2021, Clin Transl Med (PMID 33783984) — GlyNAC pilot in older adults

onlinelibrary.wiley.com · 2021
View Study
Was this helpful?
Your feedback shapes what we research deeper.

How was your experience with this compound?

Anonymous · one vote per session · results below at 5+ votes.

Loading…

See something off?

Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.

Discussion — click to load
Loading…
Continue: Extended research →
Our verdict, decision matrix, deep dives, controversies, sources